Denali Therapeutics Inc
DNLI
$17.61-3.98%
End of day · as of Oct 16, 2026, 8:00 PM ET
Mkt cap
$2.11B
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (TTM)
$-2.84
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
1.33
Div yield
N/A
Sector
Healthcare
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
Latest reported DNLI revenue for 2025-12-31 was $0. Net income was -$512.5M. DNLI currently screens at market cap $2.11B.
Use this DNLI research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full DNLI income, balance, and cash tables.
Denali Therapeutics Inc (DNLI) is a biotechnology company in the Healthcare sector.
Latest cached Denali Therapeutics Inc (DNLI) net income for Dec 31, 2025 was -$512.5M. Statements: https://lician.com/financials/dnli
Denali Therapeutics Inc (DNLI) market capitalization is $2.11B on the latest cached snapshot.
Denali Therapeutics Inc (DNLI) cached previous close $18.34; day range $17.54 – $18.37; volume 2,304,258. Session quote: https://lician.com/quote/dnli
Denali Therapeutics Inc (DNLI) latest cached earnings event is "DNLI earnings" on Aug 10, 2026. Earnings calendar: https://lician.com/earnings
The latest cached DNLI filing is 8-K · Jul 28, 2026. Filings: https://lician.com/sec/dnli